Category: Funding RoundupSyndicate content

Acutus Medical pulls in $26M

September 30, 2014 by Alexander Soule

Acutus Medical secured $26.2 million in new funding for its cardiac mapping technology.

Acutus Medical pulls in $26M

Acutus Medical said it secured $26.2 million in new funding for the cardiac mapping technology it's developing to image and map atrial fibrillation hotspots.

'Frotox' maker Myoscience raises $8m

September 30, 2014 by Alexander Soule

Myoscience secures $8.4 million in new funding for its 'frotox' device that applies extreme cold to the skin to temporarily treat pain and smooth wrinkles.

'Frotox' maker Myosure raises $8m

Myoscience said it landed $8.4 million of a hoped-for $11.5 million for a device that applies extreme cold to the skin as a way to temporarily treat pain and smooth wrinkles.

Cohealo raises $3m for medical device sharing software

September 29, 2014 by Alexander Soule

Cohealo reports a $3.2 million debt round for the software it's developing to help hospitals manage their shared medical device inventory.

Cohealo raises $3m for medical device inventory management solution

Cohealo reported raising $3.1 million of a hoped-for $5.8 million in debt financing as it develops software to help hospitals manage their shared medical device inventory.

Silicon Valley Bank's Ben Johnson talks early-stage medtech investment slump | Medtech funding for the week of September 22, 2014

September 26, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: What's behind the slump in early-stage medtech investment?; iHealth realigns, eyes the globe with new $25M investment; Ivantis adds $25M, eyes U.S. approval for glaucoma micro-stent; Minerva Surgical's just an inch away from closing a $25.5M round; Palmaz Scientific uncorks more funding

What's behind the slump in early-stage medtech investment?

September 24, 2014 by Brad Perriello

What's behind the slump in early-stage medtech investment?

September 24, 2014 by Brad Perriello

Blame the medical device tax and the U.S. regulatory environment for the slump in investment in early-stage medical technologies, Silicon Valley Bank's Ben Johnson tells MassDevice.com.

What's behind the slump in early-stage medtech investment?

It's a hard world out there for those looking to turn their cutting edge medical device ideas into commercial products, with investors shying away from early-stage companies in favor of more established medtech enterprises.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Vital Therapies looks to tap the market for $46M more

September 24, 2014 by Alexander Soule

Vital Therapies looks to raise another $46 million in a public stock offering as it works on its liver regeneration technology.

Vital Therapies looks to tap the market for $46M more

Vital Therapies (NSDQ:VTL) registered a $46 million public stock offering for its technique for the regeneration of liver tissue.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Palmaz Scientific uncorks more funding

September 24, 2014 by Alexander Soule

Palmaz Scientific, founded by stent pioneer Dr. Julio Palmaz, raises another $1.3 million for the prosthetic implant technology it's developing.

Palmaz uncorks more funding

Palmaz Scientific recorded $1.3 million of a planned $4.2 million funding round for the prosthetic implant technology it's developing in Dallas.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp